Utility of multiparametric MRI at 3 tesla and MRI/ultrasound fusion-guided biopsy in detecting seminal vesicle invasion by prostate cancer.

Authors

null

Dima Raskolnikov

Urologic Oncology Branch, National Cancer Institute at the National Institutes of Health, Bethesda, MD

Dima Raskolnikov , Soroush Rais-Bahrami , Arvin George , Baris Turkbey , Chinonyerem Okoro , Jason Rothwax , Nabeel Shakir , Annerleim Walton-Diaz , Minhaj Siddiqui , Daniel Su , Lambros Stamatakis , Bradford J. Wood , Peter L. Choyke , Peter A. Pinto

Organizations

Urologic Oncology Branch, National Cancer Institute at the National Institutes of Health, Bethesda, MD, Molecular Imaging Program, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD, Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, MD

Research Funding

No funding sources reported

Background: We aim to evaluate the correlation between multiparametric prostate MRI (MP-MRI) suspicion for seminal vesicle invasion (SVI) and pathology on MRI/US fusion-guided biopsy, as well as radical prostatectomy (RP). Methods: 822 patients underwent MP-MRI and MRI/US fusion-guided biopsy. 24 patients underwent targeted seminal vesicle biopsies. 5 patients had MRI findings suspicious for bilateral SVI, for a total of 29 lesions. MP-MRI targets were scored as low, moderate, or high suspicion for PCa involvement according to the validated NIH scoring system. Patient demographics were reviewed and positive predictive values (PPVs) of pre-biopsy suspicion levels were calculated with respect to correlative biopsy pathology and final RP pathology. Results: At the time of MP-MRI, the median age was 64 years with a median PSA of 10.74 ng/ml (Table). Thirteen (54.2%) had not been previously diagnosed with PCa. Of the 29 SV lesions on imaging, MP-MRI suspicions of low, moderate, and high were assigned to 3, 18, and 8 lesions, respectively. The PPVs of these MRI suspicion levels, confirmed by MRI/US fusion biopsy, were 0%, 77.7%, and 62.5%, respectively. The 3 patients in the low suspicion cohort all underwent RP, confirming targeted biopsy findings. Of those with moderate or high suspicion of SVI on MP-MRI, only 5 underwent RP, with a targeted biopsy accuracy of 80%. The overall accuracy of targeted SV biopsy was 87.5% (7/8) on final RP pathology. Conclusions: MP-MRI suspicion of SVI correlates highly with findings on targeted SV biopsy and final RP pathology, thus potentially playing a vital role in future preoperative staging for PCa.

Patient demographics and MP-MRI imaging characteristics.
Total # patients n, (%) 24 (100) # MP-MRI SV lesions 29
Age [years] median, (range) 64 (45–74) Suspicion score
Race n, (%) Low PPV = 0%
White 14 (58.3) Biopsy SVI+ (n) 0
Black 8 (33.3) Total (n) 3
Other 2 (8.3) Moderate PPV = 77.7%
PSA [ng/ml] median, (range) 10.74 (0.52–231.6) Biopsy SVI+ (n) 141
Pre-MRI clinical stage Total (n) 18
No h/o PCa (n), (%) 13 (54.2) High PPV = 62.5%
Prior h/o PCa (n), (%) 11 (45.8) Biopsy SVI+ (n) 52
cT1c (n) 9 Total (n) 8
cT2a (n) 2

1 Gleason 3+4 through 10. 2 Gleason 4+4 through 10.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 128)

DOI

10.1200/jco.2014.32.4_suppl.128

Abstract #

128

Poster Bd #

H5

Abstract Disclosures